Further investigation is required to decipher whether extrinsic factors such as the CLL microenvironment as well as the concurrence with other genetic alterations would play a critical role in fludarabine resistance of BIRC3 mutated CLL cells. This evidence concerns the gene BIRC3 and B-cell chronic lymphocytic leukemia.